FFA1-selective agonistic activity based on docking simulation using FFA1 and GPR120 homology models.
about
A novel antidiabetic drug, fasiglifam/TAK-875, acts as an ago-allosteric modulator of FFAR1The therapeutic potential of GPR120: a patent review.Therapeutic role and ligands of medium- to long-chain Fatty Acid receptors.Free Fatty Acid Receptor 1 (FFAR1) as an Emerging Therapeutic Target for Type 2 Diabetes Mellitus: Recent Progress and Prevailing Challenges.Application of GPCR Structures for Modelling of Free Fatty Acid Receptors.Ligands at Free Fatty Acid Receptor 1 (GPR40).
P2860
FFA1-selective agonistic activity based on docking simulation using FFA1 and GPR120 homology models.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
FFA1-selective agonistic activ ...... A1 and GPR120 homology models.
@en
FFA1-selective agonistic activ ...... A1 and GPR120 homology models.
@nl
type
label
FFA1-selective agonistic activ ...... A1 and GPR120 homology models.
@en
FFA1-selective agonistic activ ...... A1 and GPR120 homology models.
@nl
prefLabel
FFA1-selective agonistic activ ...... A1 and GPR120 homology models.
@en
FFA1-selective agonistic activ ...... A1 and GPR120 homology models.
@nl
P2093
P2860
P1476
FFA1-selective agonistic activ ...... A1 and GPR120 homology models.
@en
P2093
Akira Hirasawa
Gozoh Tsujimoto
Ikuo Kimura
Masaji Ishiguro
Masato Takeuchi
Naoki Miyata
Takafumi Hara
Takayoshi Suzuki
Takeo Awaji
Tatsuya Hirano
P2860
P304
P356
10.1111/J.1476-5381.2012.02052.X
P407
P577
2013-04-01T00:00:00Z